my iPS is a project in which individuals can purchase their own iPS cells at a reasonable price. Although autologous transplantations are safest from the perspective of immune rejection, they are costly and time consuming.
To make iPS cell therapies accessible to the large population, the CiRA Foundation is developing technologies that will manufacture one's own iPS cells at low cost.
Manufacturing cells at a cost of 1 million yen by 2025
Currently, the manufacturing of iPS cells takes several months and costs several tens of million yen. Reducing the time and cost must be done without compromising the safety or efficacy of the iPS cells. We therefore seek the collaboration of companies and scientists to achieve this goal.